π End of Day Bhavcopy
Date: 2025-09-09
Price: 198.30
% Change: -0.43% (Prev Close: 199.16)
Volume: 15,12,574
% Change: -1.32% (Prev Volume: 15,32,805)
Delivery: 7,50,503
Delivery % : 49.62
% Change: 39.56% (Prev Delivery: 5,37,768)
Turnover: 3,002 Lacs
% Change: -2.09% (Prev Turnover: 3,066)
πΉ EOD Valuation
P/E Ratio: 267.97
P/B Ratio: 3.24
Market Cap: 26358 Rs. Cr.
Fundamental Data
Date: 05-09-2025
π·οΈ Company Basics
Symbol: PPLPHARMA
Market Cap: 24384 Rs. Cr.
Face Value: 10.00 Rs.
52 Week High: 307.90
52 Week Low: 180.35
All-Time High: 307.90 Rs.
All-Time Low: 61.62 Rs.
Stock Price Increase (% Return) %
% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
3.94% | -2.51% | -0.15% | -5.57% | 0.00%
π₯ Shareholding Pattern
Promoter Holding
Promoter Holding: 34.86%
Change (3Y | 1Y): 0.00% | -0.09%
Pledged %: 0.00%
FII Holding
FII Holding: 30.86%
Change (3Y | 1Y): 0.00% | -0.63%
DII Holding
DII Holding: 14.25%
Change (3Y | 1Y): 0.00% | -0.53%
Public Holding: 19.46%
π¦ Financial Strength
Debt to Equity: 0.60
Debt: 4856.47 Rs. Cr.
Book Value: 61.29 Rs.
Current Ratio: 1.53
Interest Coverage: 1.90
Free Cash Flow: 233.17 Rs. Cr.
π Growth & Sales
Sales Growth: 9.08%
Sales Growth Qtr (YOY | QoQ):
-0.89% | -29.79%
Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | 11.74% | 9.08%
π° Profit & Earnings
Profit Growth %
Profit Growth: 114.43%
Profit Growth Qtr (YOY | QoQ):
-5.44% | -153.22%
Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | -38.63% | 114.43%
EPS Rs.
EPS (TTM): 0.74 Rs.
EPS Qtr (Last Year | Latest):
-0.67 Rs. | -0.61 Rs.
EPS Annual (Last Annual | Annual March):
0.13 Rs. | 0.69 Rs.
EPS Growth Variation % (5 Yrs | 3 Yrs):
0.00% | 0.00%
Net Profit Rs. Cr.
Net Profit (TTM): 98.07 Rs. Cr.
Net Profit (Annual - March): 91.13 Rs. Cr.
Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
-88.64| 153.50 | -81.70
EBITDA Rs. Cr.
EBITDA (Quarter): 183.67 Rs. Cr.
EBITDA (Previous Yr Ql): 246.43 Rs. Cr.
EBITDA (Annual - March): 1642.08 Rs. Cr.
EBITDA (Previous Annual): 1427.25 Rs. Cr.
EBITDA (5 Yrs | 3 Yrs) %:
0.00% | 8.57%
π Profitability Ratios
Operating Margin (OPM)
OPM (TTM): 14.75%
OPM Qtr (Previous | Current):
20.37% | 5.52%
OPM Annual (5 Yrs | Last Yr | March):
15.15% | 14.65% | 15.79%
Return on Equity %
ROE: 1.11%
ROE (5 Yrs | 3 Yrs | Last Yr):
0.00% | -0.37% | 0.22%
Return on Capital Employed %
ROCE: 6.45%
ROCE (5 Yrs | 3 Yrs | Last Yr):
5.27% | 4.64% | 5.49%
Return on Assets %
ROA (TTM): 0.58%
ROA (5 Yrs | 3 Yrs | Last Yr):
0.00% | -0.23% | 0.11%
PEG Ratio: -7.31
Dividend Yield: 0.08%
PE 3 Yrs: 566.14
PE 5 Yrs: 566.14
Dividend Yield: 0.08%
π₯ Company
Piramal Pharma Ltd
PPLPHARMA
Promoter Holding: %